Bentham Science Logo

Track Your Manuscript:

Current Drug Targets

Volume 22, 17 Issues, 2021
ISSN: 1873-5592 (Online)
ISSN: 1389-4501 (Print)
This journal supports open access


Current Drug Targets, Volume 17 - Number 5

Targeting of Peptide Cytotoxins to LHRH Receptors For Treatment of Cancer

, 17(5): 488 - 494

Jorg B. Engel, Hans-Rudolf Tinneberg, Ferenc G. Rick, Enniko Berkes and Andrew V. Schally

DOI: 10.2174/138945011705160303154717

Gastrin-Releasing Peptide Receptor Targeting in Cancer Treatment: Emerging Signaling Networks and Therapeutic Applications

, 17(5): 508 - 514

Mikko O. Laukkanen and Maria Domenica Castellone

DOI: 10.2174/1389450116666151001112130

CXCR3, CXCR5, CXCR6, and CXCR7 in Diabetes

, 17(5): 515 - 519

Poupak Fallahi, Alda Corrado, Andrea Di Domenicantonio, Giada Frenzilli, Alessandro Antonelli and Silvia Martina Ferrari

DOI: 10.2174/1389450115666141229153949

EGFR Transactivation by Peptide G Protein-Coupled Receptors in Cancer

, 17(5): 520 - 528

Terry W. Moody, Bernardo Nuche-Berenguer, Taichi Nakamura and Robert T. Jensen

DOI: 10.2174/1389450116666150107153609


Francis J. Castellino
(14643 citations)
Dean Emeritus, College of Science,
Kleiderer-Pezold Professor of Biochemistry
Director, W.M. Keck Center for Transgene Research
230 Raclin-Carmichael Hall, University of Notre Dame
Notre Dame, IN 46556
View Full Editorial Board

COPE Compliant

Cope Logo

Journal History

Current Drug Targets Journal was launched in 2000. Dr. Francis J. Castellino serves as the Editor-in-Chief of the journal.

Related Journals

Related eBooks

eBooks Catalog